Collection
Dementia
- Submission status
- Open
- Open for submission from
- 20 August 2021
- Submission deadline
- Ongoing
A collection of recent articles discussing the pharmacological treatment of dementia
Articles (18 in this collection)
-
-
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Authors (first, second and last of 7)
- Solana Leisher
- Adriana Bohorquez
- Michael S. Rafii
- Content type: Review Article
- Open Access
- Published: 20 July 2023
- Pages: 671 - 677
-
Role of Pharmacogenomics in Individualizing Treatment for Alzheimer’s Disease
Authors
- Natalie Argueta
- Emily Notari
- Kinga Szigeti
- Content type: Review Article
- Published: 30 March 2022
- Pages: 365 - 376
-
Pharmacological Management of Apathy in Dementia
Authors (first, second and last of 5)
- Laiba Azhar
- Raphael W. Kusumo
- Nathan Herrmann
- Content type: Review Article
- Published: 10 January 2022
- Pages: 143 - 165
-
Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia
Authors
- Christine Le
- Elizabeth Finger
- Content type: Review Article
- Published: 24 August 2021
- Pages: 1081 - 1096
-
Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy
Authors
- Ethan S. Burstein
- Content type: Review Article
- Open Access
- Published: 05 July 2021
- Pages: 727 - 741
-
Pharmacotherapy for Frontotemporal Dementia
Authors (first, second and last of 4)
- Rita Khoury
- Yu Liu
- George T. Grossberg
- Content type: Review Article
- Published: 11 April 2021
- Pages: 425 - 438
-
Intranasal Insulin for Alzheimer’s Disease
Authors
- Manfred Hallschmid
- Content type: Review Article
- Open Access
- Published: 30 January 2021
- Pages: 21 - 37
-
Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
Authors
- Michael S. Rafii
- Content type: Leading Article
- Published: 06 June 2020
- Pages: 785 - 794
-
Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
Authors (first, second and last of 16)
- Tamàs Fülöp
- Usma Munawara
- Eric Frost
- Content type: Current Opinion
- Published: 26 May 2020
- Pages: 673 - 695
-
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease
Authors
- Lucia Caffino
- Francesca Mottarlini
- Fabio Fumagalli
- Content type: Review Article
- Published: 12 February 2020
- Pages: 281 - 297
-
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
Authors (first, second and last of 6)
- Monika Marcinkowska
- Joanna Åšniecikowska
- Marcin Kołaczkowski
- Content type: Review Article
- Open Access
- Published: 12 February 2020
- Pages: 243 - 268
-
Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia
Authors (first, second and last of 4)
- Eline J. Vredeveld
- Tessa A. Hulshof
- Hendrika J. Luijendijk
- Content type: Original Research Article
- Open Access
- Published: 31 August 2019
- Pages: 933 - 942
-
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Authors (first, second and last of 4)
- Chiara Lanzillotta
- Fabio Di Domenico
- D. Allan Butterfield
- Content type: Leading Article
- Published: 13 August 2019
- Pages: 957 - 969
-
Endolysosome and Autolysosome Dysfunction in Alzheimer’s Disease: Where Intracellular and Extracellular Meet
Authors
- Jan R. T. van Weering
- Wiep Scheper
- Content type: Leading Article
- Open Access
- Published: 04 June 2019
- Pages: 639 - 648
-
Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines
Authors (first, second and last of 10)
- Matthew J. Sharman
- Giuseppe Verdile
- Gerald Münch
- Content type: Review Article
- Published: 21 March 2019
- Pages: 457 - 480
-
A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
Authors
- Brati Das
- Riqiang Yan
- Content type: Review Article
- Published: 04 March 2019
- Pages: 251 - 263
-
Alzheimer’s Disease Clinical Trials: Moving Toward Successful Prevention
Authors
- Michael S. Rafii
- Paul S. Aisen
- Content type: Current Opinion
- Published: 17 December 2018
- Pages: 99 - 106